Who
Mo Qatanani
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Scholar Rock Holding.
In numbers
- Trades disclosed
- 82
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $15.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Sep 2023
- Last trade
- 23 Feb 2026
- Last filed
- 25 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $349K7,427 at $46.94 | filing |
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $41K857 at $47.86 | filing |
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $9,696200 at $48.48 | filing |
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $349K7,427 at $46.94 | filing |
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $41K857 at $47.86 | filing |
| 23 Feb 2026filed 25 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $9,696200 at $48.48 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $372K7,989 at $46.53 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $372K7,989 at $46.53 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —29,258 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —29,258 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $97K2,119 at $45.87 | filing |
| 22 Jan 2026filed 23 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $599K12,779 at $46.85 | filing |
| 22 Jan 2026filed 23 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $97K2,119 at $45.87 | filing |
| 22 Jan 2026filed 23 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $599K12,779 at $46.85 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $374K8,406 at $44.48 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $374K8,406 at $44.48 | filing |
| 14 Jan 2026filed 16 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code M | $25K1,407 at $18.08 | filing |
| 14 Jan 2026filed 16 Jan 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,893 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,678 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code M | $2,446321 at $7.62 | filing |
News
Scholar Rock Resubmits Marketing Authorisation Application For ApitegromabSRRK · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Mo Qatanani; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.